Seeking Alpha
 

Sequenom, Inc. (SQNM)

- NASDAQ
  • Dec. 19, 2011, 8:01 AM
    Sequenom (SQNM) rises 4% after announcing "numerous leading healthcare providers" in the U.S. have begun ordering its MaterniT21 product, which is used to analyze a baby's DNA during pregnancy for signs of Down Syndrome. Ed Pullen believes the nature of Sequenom's product "raises huge questions" about its usage. (previously)
    | Dec. 19, 2011, 8:01 AM | 1 Comment
  • Nov. 23, 2011, 11:02 AM
    Sequenom (SQNM -5.3%) sells off after filing for a $150M mixed shelf offering consisting of common stock, preferred stock, debt, and warrants. The maker of DNA analysis products says it plans to use the proceeds for "general corporate purposes."
    | Nov. 23, 2011, 11:02 AM | 2 Comments
  • Oct. 17, 2011, 10:38 AM
    Shares of Sequenom (SQNM +11.1%) pop after the company announces the launch of its MaterniT21 noninvasive prematernal test for Down syndrome. The test is now available in 20 metropolitan cities for expectant women.
    | Oct. 17, 2011, 10:38 AM | Comment!
  • May 9, 2011, 9:00 AM
    Premarket gainers: INO +13%. DTG +9%. BSFT +8%. AFFX +7%. ALKS +6%. EXK +5%. GPL +5%. SYY +5%. ELN +4%. HL +4%. SQNM +3%. CEF +3%. SD +3%.
    Losers: ZSL -11%. ZRAN -10%. GKK -8%. IRE -3%. LEXG -3%.
    | May 9, 2011, 9:00 AM | Comment!
  • Dec. 2, 2010, 9:00 AM
    Premarket gainers: WBD +30%. RNN +22%. PSS +16%. ANF +8%. WTSLA +8%. S +8%. FNSR +6%. SGMO +5%. STP +4%.
    Losers: SQNM -9%. ARO -9%. SEP -4%. AEO -4%.
    | Dec. 2, 2010, 9:00 AM | Comment!
  • Sep. 22, 2010, 9:00 AM
    Premarket gainers: SEED +13%. BQI +8%. SAY +7%. PWER +4%. VVUS +5%.
    Losers: VICL -36%. ADBE -21%. FUR -8%. BIIB -5%. EBAY -5%. ELN -4%. SQNM -4%. HIG -4%.
    | Sep. 22, 2010, 9:00 AM | Comment!
  • Jul. 13, 2010, 9:00 AM
    Premarket gainers: YRCW +25%. ABK +12%. MBI +11%. VVUS +10%. OREX +6%. CENX +5%. NBG +5%. PMI +5%. IRE +5%. AA +4%. CTIC +4%. X +4%. BANR +4%. ERIC +4%.
    Losers: CVLT -25%. AMED -11%. ATPG -9%. SQNM -4%.
    | Jul. 13, 2010, 9:00 AM | Comment!
  • Jun. 11, 2010, 9:00 AM
    Premarket gainers: ARST +13%. WEN +11%. YRCW +10%. XIDE +6%. BP +5%. SQNM +5%. DCTH +4%. STD +4%.
    Losers: RTP -4%.
    | Jun. 11, 2010, 9:00 AM | Comment!
  • May 7, 2010, 9:00 AM
    Premarket gainers: NCT +22%. PCBC +11%. AEZS -8%. CYTX +8%. CRXX +7%. CTIC +6%. CIM +6%. PMI +5%. VTIV +6%. ABK +5%. YRCW +5%. BHP +4%. CROX +4%. RTP +4%. INFN +4%. EXM +4%. CS +4%. STD +4%. AIXG +4%.
    Losers: GXDX -15%. SQNM -7%. GBX -7%. OCLRD -7%. IMGN -6%. XOMA -5%. FSS -5%.
    | May 7, 2010, 9:00 AM | Comment!
  • May 6, 2010, 4:36 PM
    Sequenom (SQNM): Q1 EPS of -$0.27 in-line. Revenue of $11M (+22.1%) vs. $10M. Shares -1.4% AH. (PR)
    | May 6, 2010, 4:36 PM | Comment!
  • May 6, 2010, 12:10 AM
    Notable earnings after Thursday's close: BGC, CFN, CIM, CLNE, CNQ, CROX, DCT, ED, KFT, LBTYA, LEAP, LVS, MIL, NHP, PKI, PSA, ROVI, SAPE, SD, SGMS, SQNM, WRI
    | May 6, 2010, 12:10 AM | Comment!
  • Apr. 28, 2010, 9:10 AM
    Premarket gainers: NBG +10%. TSFG +8%. CIIC +7%. NVAX +8%. BCRX +7%. RFMD +6%. TLAB +6%. ACAS +6%. RNN +6%. YRCW +5%. ABK +5%. PCBC +5%. MPEL +5%. ERIC +5%. UAUA +4%. LCC +4%. DCTH +4%. TMO +4%. CRBC +4%. CMCSA +4%. GT +4%. CHU +4%. SQNM +4%.
    Losers: BWLD -19%. RHI -11%. CNXT -10%. FBC -10%. PFCB -4%.
    | Apr. 28, 2010, 9:10 AM | 1 Comment
  • Apr. 19, 2010, 9:00 AM
    Premarket gainers: CRN +35%. YMI +9%. CTIC +5%. IMMU +4%. SQNM +4%.
    Losers: RNN -13%. TSFG -7%. SPF -7%. PALM -6%. FRE -5%. FNM -5%.
    | Apr. 19, 2010, 9:00 AM | Comment!
  • Mar. 23, 2010, 9:23 AM
    Lazard boosts Sequenom (SQNM) to Buy, saying last week's selloff presents an opportunity for buyers, "based on our view that it is more likely than not that SQNM will be able to create a test for Down syndrome with third-party data showing it to be more accurate than current screening." SQNM +12% to $6.18 premarket.
    | Mar. 23, 2010, 9:23 AM | Comment!
  • Mar. 16, 2010, 9:05 AM
    Premarket gainers: CGEN +10%. ANPI +8%. ATHN +8%. MPEL +7%. CTIC +5%. DNN +5%. OFG +4%. GKK +4%. PDC +4%. MNKD +4%.
    Losers: SQNM -18%. LXRX -13%. GEL -6%. GLP -6%. GSI -4%.
    | Mar. 16, 2010, 9:05 AM | Comment!
  • Mar. 15, 2010, 4:15 PM
    Sequenom (SQNM): Q4 EPS of -$0.30 misses by $0.05. Revenue of $11M (-11.5%) vs. $9M. Shares -1.4% AH. (PR)
    | Mar. 15, 2010, 4:15 PM | Comment!
Visit Seeking Alpha's
SQNM vs. ETF Alternatives
Company Description
Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.
Sector: Healthcare
Industry: Biotechnology
Country: United States